- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Recurrent Intraocular Melanoma in Norway
Total 183 results
-
Steinar AamdalTerminatedMetastatic Malignant MelanomaNorway
-
Oslo University HospitalCompleted
-
Haukeland University HospitalNorwegian Cancer Society; The Norwegian Melanoma GroupTerminatedMetastatic Malignant Melanoma | Unresectable Malignant MelanomaNorway
-
Ultimovacs ASAOslo University HospitalActive, not recruiting
-
Haukeland University HospitalHoffmann-La Roche; Norwegian Cancer SocietyCompleted
-
Ullevaal University HospitalCompleted
-
Oslo University HospitalCompleted
-
Oslo University HospitalActive, not recruitingMalignant MelanomaNorway
-
University Hospital of North NorwayCompletedMelanoma (Skin) | Actinic Keratoses | Non-melanoma Skin CancerNorway
-
Clavis PharmaCompletedMalignant MelanomaUnited States, Sweden, Norway
-
Haukeland University HospitalBerGenBio ASAActive, not recruiting
-
Oslo University HospitalCompletedEarly Complications After Axillary and Inguinal Lymph Node Dissection in Stage III Melanoma PatientsMelanoma | ComplicationNorway
-
Oslo University HospitalInstitute for Molecular MedicineRecruitingRecurrent GlioblastomaNorway
-
Clavis PharmaCompletedNeoplasm Metastasis | Malignant MelanomaUnited States, Norway, Sweden
-
Haukeland University HospitalNorthwell Health; University of Bergen; Weill Medical College of Cornell University and other collaboratorsCompletedGlioma | Glioblastoma | Recurrent GlioblastomaNorway
-
Lytix Biopharma ASLaboratory Corporation of America; OWLActive, not recruitingAdvanced MelanomaUnited States, Spain, France, Norway
-
University Hospital of North NorwayUniversity of Tromso; The Research Council of NorwayCompleted
-
Targovax OyCompletedAdvanced or Unresectable Melanoma Progressing After PD1 BlockadeUnited States, Norway
-
University Hospital of North NorwayNorwegian Council on Cardiovascular diseasesCompletedIntraocular Pressure | Insulin SensitivityNorway
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruitingMelanoma Stage IvAustralia, Norway
-
Bristol-Myers SquibbCompletedUnresectable Stage III or IV Malignant MelanomaUnited States, Peru, Norway, Italy, Sweden, Denmark, Israel
-
Oslo University HospitalSouth-Eastern Norway Regional Health AuthorityUnknown
-
Oslo University HospitalUnknownIntraocular Lens DislocationNorway
-
GlaxoSmithKlineTerminatedMelanomaNorway, Argentina, Greece
-
National Cancer Institute (NCI)Active, not recruitingStage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
European Organisation for Research and Treatment...CompletedMelanoma (Skin)France, Switzerland, Norway, Belgium, United Kingdom, Germany, Austria, Portugal, Italy
-
Novartis PharmaceuticalsTerminatedUveal MelanomaUnited States, Australia, France, Netherlands, Spain, Norway
-
Oslo University HospitalRecruitingLocally Advanced Pelvic Cancer That Require Pelvic ExenterationNorway
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable Melanoma | Advanced Melanoma | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
National Cancer Institute (NCI)Active, not recruitingStage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Melanoma of Unknown Primary | Stage IIIB Cutaneous Melanoma AJCC v7United States, Canada
-
University of OsloGöteborg University; UMC Utrecht; Medical University of Lodz; Amsterdam UMC, location...Enrolling by invitationRecurrent Urinary Tract InfectionNetherlands, Norway, Poland, Sweden
-
Steinar AamdalTerminatedRecurrent Epithelial Ovarian CancerNorway
-
PfizerCompletedMelanoma and Metastatic Colorectal CancerUnited States, Spain, France, Japan, Australia, Switzerland, Norway
-
European Organisation for Research and Treatment...TerminatedMetastatic Cancer | Melanoma (Skin)France, Norway, Belgium, Netherlands, United Kingdom, Austria, Czech Republic, Germany, Italy, Portugal, Switzerland
-
European Organisation for Research and Treatment...UnknownMelanoma (Skin)Italy, France, Spain, Switzerland, United Kingdom, Belgium, Australia, Norway, Poland, Finland, Netherlands, Germany, Israel, Denmark, Serbia, Estonia, Portugal, Russian Federation
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Catharina Ziekenhuis EindhovenRecruitingRecurrent Rectal CancerNetherlands, Sweden, Belgium, Norway, Portugal
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingMelanomaArgentina, United States, Australia, Austria, Belgium, Canada, Czechia, Finland, France, Greece, Hungary, Ireland, Italy, Japan, Korea, Republic of, Netherlands, Norway, Poland, Romania, South Africa, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
Medical University of ViennaRecruitingMedulloblastoma Recurrent | Ependymoma Recurrent | ATRT RecurrentAustria, Sweden, France, Spain, United States, Czechia, Denmark, Norway
-
Bristol-Myers SquibbCompletedMelanomaItaly, Netherlands, Russian Federation, Czechia, Hungary, Ireland, Norway, Spain, Switzerland, Austria, Germany, Denmark, France, Belgium, United Kingdom, United States
-
Merck Sharp & Dohme LLCTerminatedAdvanced/Metastatic MelanomaUnited States, Australia, Chile, France, Germany, Israel, Italy, Korea, Republic of, Norway, South Africa, Spain
-
Melanoma and Skin Cancer Trials LimitedUniversity of Oxford; Trans Tasman Radiation Oncology GroupActive, not recruitingMetastatic MelanomaNorway, Australia, United Kingdom
-
Ultimovacs ASACompletedMalignant MelanomaUnited States, Belgium, United Kingdom, Norway
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
National Cancer Institute (NCI)Active, not recruitingUnresectable Cutaneous Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Melanoma of Unknown Primary | Mucosal Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
Bristol-Myers SquibbActive, not recruitingUnresectable or Metastatic MelanomaUnited States, France, Poland, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, Germany, Ireland, Israel, Italy, Netherlands, New Zealand, Norway, Spain, Sweden, Switzerland, United Kingdom, Russian Federation
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI); NCIC Clinical Trials Group; Children's Oncology... and other collaboratorsActive, not recruitingMelanoma (Skin)United States, Canada, Australia, South Africa